| Literature DB >> 36006284 |
Victor Abiola Adepoju1, Kelechi Elizabeth Oladimeji2, Olusola Adedeji Adejumo3, Oluwatoyin Elizabeth Adepoju4, Ademola Adelekan5, Olanrewaju Oladimeji2.
Abstract
Studies specifically evaluating tuberculosis knowledge among private non-NTP providers using the International Standards for Tuberculosis Care (ISTC) framework are scarce. We evaluated the knowledge of ISTC among private non-NTP providers and associated factors in urban Lagos, Nigeria. We performed a cross-sectional descriptive study using a self-administered questionnaire to assess different aspects of tuberculosis management among 152 non-NTP providers in Lagos, Nigeria. The association between the dependent variable (knowledge) and independent variables (age, sex, qualifications, training and years of experience) was determined using multivariate logistic regression. Overall, the median knowledge score was 12 (52%, SD 3.8) and achieved by 47% of the participants. The highest knowledge score was in TB/HIV standards (67%) and the lowest was in the treatment standards (44%). On multivariate analysis, being female (OR 0.3, CI: 0.1-0.6, p < 0.0001) and being a nurse (OR 0.2, CI: 0.1-0.4, p < 0.0001) reduced the odds of having good TB knowledge score, while having previously managed ≥100 TB patients (OR 2.8, CI: 1.1-7.2, p = 0.028) increased the odds of having good TB knowledge. Gaps in the knowledge of ISTC among private non-NTP providers may result in substandard TB patient care. Specifically, gaps in knowledge of standard TB regimen combinations and Xpert MTB/RIF testing stood out. The present study provides evidence for tailored mentorship and TB education among nurses and female private non-NTP providers.Entities:
Keywords: international standards for TB care; knowledge; private non-NTP providers; tuberculosis
Year: 2022 PMID: 36006284 PMCID: PMC9414366 DOI: 10.3390/tropicalmed7080192
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Figure 1Flowchart showing stepwise study selection of private unengaged providers Lagos, Nigeria. HEFAMAA—Health Facility Monitoring and Accreditation Agency, AGPMPN—Association of General Private Medical Practitioners of Nigeria, AGPN—Association of General Private Nurses, LSTBLCP—Lagos State Tuberculosis, Buruli Ulcer and Leprosy Control Program.
Demographic characteristics and participants’ level of awareness and knowledge of TB.
| Variable | Frequency | Percent |
|---|---|---|
|
| ||
| 20–34 | 56 | 36.8 |
| 35–49 | 46 | 30.3 |
| 50–64 | 40 | 26.3 |
| >65 | 10 | 6.6 |
|
| ||
| Male | 63 | 41.4 |
| Female | 89 | 58.6 |
|
| ||
| Private Not-For-Profit | 13 | 8.6 |
| Private For-Profit | 139 | 91.4 |
|
| ||
| NO | 36 | 23.7 |
| YES | 116 | 76.3 |
|
| ||
| NO | 93 | 61.2 |
| YES | 59 | 38.8 |
|
| ||
| NO | 52 | 34.2 |
| YES | 100 | 65.8 |
|
| ||
| <100 | 57 | 37.5 |
| 100–200 | 46 | 30.3 |
| 200–500 | 33 | 21.7 |
| >500 | 16 | 10.5 |
|
| ||
| MBBS/GP | 60 | 39.5 |
| NURSE/MIDWIVE | 92 | 60.5 |
|
| ||
| 1–16 | 73 | 53.3 |
| 17–44 | 64 | 46.7 |
|
| ||
| NO | 61 | 40.1 |
| YES | 91 | 59.9 |
|
| ||
| NO | 106 | 69.7 |
| YES | 46 | 30.3 |
|
| ||
| <1 | 9 | 19.6 |
| 1–5 | 18 | 39.1 |
| 5–10 | 14 | 30.4 |
| >10 | 5 | 10.9 |
NTBLCP—National TB, Leprosy and Buruli Ulcer Control Program; GP—general practitioner; MBBS—Bachelor of Medicine and Surgery; DOTS—Directly Observed Therapy Short course.
Participants’ responses to questions assessing knowledge of tuberculosis diagnosis, treatment, TB/HIV co-infection, public health and patient rights.
| Standard 1 (TB Diagnosis) | Correct Answer (%) | Incorrect Answer (%) | ||
|---|---|---|---|---|
| 1 | Which of the following tests requires a blood sample for the diagnosis of TB | 42 (27.6) | 110 (72.4) | |
| 2 | TB is most frequently caused by | 139 (91.4) | 13 (8.6) | |
| 3 | The standard test for diagnosis of tuberculosis in Nigeria is | 51 (33.6) | 101 (66.4) | |
| 4 | Where are the missing TB cases | 100 (65.8) | 52 (34.2) | |
| 5 | Which of the following is a symptom of tuberculosis | 115 (75.7) | 37 (24.3) | |
| 6 | How many sputum samples are needed for the diagnosis of TB using microscopy | 12 (7.9) | 140 (92.1) | |
| 7 | Which is TRUE concerning TB disease | 66 (43.4) | 86 (56.6) | |
|
| ||||
| 8 | Traditional treatment for drug-resistant TB lasts for how many months | 16 (10.5) | 136 (89.5) | |
| 9 | Drug-sensitive TB is treated for how many months | 111 (73.0) | 41 (27.0) | |
| 10 | Which of the following tests should be used to monitor the success of treatment | 50 (32.9) | 102 (67.1) | |
| 11 | TB treatment success is a combination of | 114 (75.0) | 38 (25.0) | |
| 12 | Which of these drugs is not a first-line anti-TB drug currently in use for the treatment of TB | 76 (50) | 76 (50.0) | |
| 13 | Concerning drug-resistant TB | 83 (54.6) | 69 (45.4) | |
| 14 | Which of the following is a possible treatment outcome for a TB patient on treatment | 119 (78.3) | 33 (21.2) | |
| 15 | What is the full meaning of the commonly used acronym DOTS | 60 (39.5) | 92 (60.5) | |
| 16 | Which of the following information is mandatory before initiating TB medication | 73 (48) | 79 (52) | |
| 17 | Which of the following is INCORRECT about DOTS | 64 (42.1) | 88 (57.9) | |
|
| ||||
| 18 | Which of the following interventions will lower the risk of active TB in people living with HIV (PLHIV) | 47 (30.9) | 105 (69.1) | |
| 19 | Which of the following is not a component of the 3Is of TBHIV collaboration | 84 (55.3) | 68 (44.7) | |
|
| ||||
| 20 | Which of these high-risk populations should be targeted for latent tuberculosis treatment | 74 (48.7) | 78 (51.3) | |
| 21 | TB can be spread typically through the following means | 46 (30.3) | 106 (69.7) | |
| 22 | The highest priority contacts for evaluation are | 82 (53.9) | 70 (46.1) | |
| 23 | Which groups are considered more likely to be exposed to or infected with M. Tuberculosis | 107 (70.4) | 45 (29.6) | |
| 24 | This is not true of latent TB infection (LTBI) and TB disease | 39 (46.4) | 45 (53.6) | |
| 25 | What is the preferred prophylaxis for the prevention of TB in eligible adults | 51 (33.6) | 101 (66.4) | |
| 26 | How to stop tuberculosis | 117 (77.0) | 35 (23.0) | |
|
| ||||
| 27 | Concerning patient rights, which is CORRECT among the following | 110 (72.4) | 42 (27.6) | |
| 28 | Which of the following is CORRECT concerning patient-centered care (PCC) versus the medical model of care | 36 (23.7) | 116 (76.3) | |
| 29 | The rights of TB patients include the following except | 62 (40.8) | 90 (59.2) | |
| 30 | In TB, program PCTC implies | 33 (21.7) | 119 (78.3) |
ISTC—International Standards for Tuberculosis Care; DOTS—Directly Observed Therapy Short Course; PCC—patient-centered care; PLHIV—people living with HIV.
Aggregate knowledge score of participants on tuberculosis standards of care.
| TB Knowledge Area | Median Score (%) | Range | S.D. |
|---|---|---|---|
| Diagnosis score | 3.0(60) | 0–5 | 1.3 |
| Treatment score | 4.0(44) | 0–9 | 1.9 |
| TB/HIV | 2.0(67) | 0–3 | 0.7 |
| Public health | 2.0(50) | 0–4 | 1.6 |
| Patient rights | 1.0(50) | 0–2 | 0.9 |
| Overall knowledge score | 12.0(52) | 0–23 | 3.8 |
Factors associated with total knowledge of tuberculosis among private non-NTP engaged providers in Lagos, Nigeria.
| Variable | Poor Knowledge (<12) | Good Knowledge (>12) | OR, 95% CI | |
|---|---|---|---|---|
|
| ||||
| Male | 22 (27.5) | 41 (56.9) | Ref. | |
| Female | 58 (72.5) | 31 (43.1) | 0.3 (0.1–0.6) | <0.0001 * |
| Age | ||||
| <35 | 26 (32.5) | 30(41.7) | 0.7 (0.3–1.3) | 0.242 |
| >35 | 54 (67.5) | 42 (58.3) | ||
|
| ||||
| PNFP | 9 (11.3) | 4 (5.6) | 2.2 (0.6–7.3) | 0.21 |
| PFP | 71 (88.8) | 68 (94.4) | ||
|
| ||||
| Yes | 27 (33.8) | 24 (34.7) | 0.9 (0.5–1.9 | 0.9 |
| No | 53 (66.3) | 47 (65.3) | ||
|
| ||||
| No | 34 (42.5) | 27 (37.5) | 1.2 (0.6–2.4) | 0.53 |
| Yes | 46 (57.5) | 45 (62.5) | ||
|
| ||||
| No | 56 (70) | 50 (69.4) | 1.0 (0.5–2.0) | 0.941 |
| Yes | 24 (30) | 22 (30.6) | ||
|
| ||||
| MBBS/GP | 17 (21.3) | 43 (59.7) | Ref. | |
| Nurse | 63 (78.8) | 29 (40.3) | 0.2 (0.1–0.4) | <0.0001 * |
|
| ||||
| <10 | 19 (41.3) | 9 (20) | Ref. | |
| 10–100 | 27 (58.7) | 36 (80) | 2.8 (1.1–7.2) | 0.028 * |
|
| ||||
| 1–16 years | 32 (50) | 38 (57.6) | 0.7 (0.4–1.5) | 0.386 |
| 17–44 years | 32 (50) | 28 (42.4) | ||
|
| ||||
| <100 | 35 (43.8) | 22 (30.6) | 1.8 (0.9–3.4) | 0.093 |
| >100 | 45 (56.3) | 50 (65.4) |
* Significant p-value < 0.05.